ACT
Enact Holdings, Inc.
ACT's outlook is improving, though it still trails on the overall score.
BAC
Bank of America Corporation
BAC has the edge over ACT overall, supported by stronger valuation and stronger fundamentals.
ACT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
ACT's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ACT.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ACT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6x | $28.70 | -37% |
| Fair | 7.6x | $36.40 | -21% |
| Expensive | 9.1x | $43.53 | -5% |
| Forward | 9.2x | $45.83 | — |
| Current | 9.5x | $45.83 | — |
Historical ranges are pointers, not guarantees.
ACT's PE is in its expensive range at 9.5x. If earnings grow as analysts expect, today's price would be 9.2x next year's earnings.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ACT in the historical PE scenario, which offers more potential upside but is not a forecast.
ACT Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect ACT's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ACT on the outlook, with more favorable valuation and revenue expectations.
ACT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.96 | +3.1% |
| Q3 2026 | $4.81 | +11% |
| Q2 2026 | $4.76 | +8.4% |
| Q1 2026 | $4.62 | +4.1% |
| Q4 2025 | $4.52 | +3.4% |
| Q3 2025 | $4.34 | +1.2% |
| Q2 2025 | $4.39 | +5.5% |
| Q1 2025 | $4.44 | +9.9% |
| Q4 2024 | $4.37 | +6.3% |
ACT's earnings per share have climbed steadily: $4.81 over the past year, up 11% from the year before, and higher year over year for nine quarters in a row.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over ACT on earnings, with stronger typical year-over-year growth.
ACT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $312.9M | +0.4% |
| Q2 2026 | $317.3M | +4.1% |
| Q1 2026 | $312.1M | +1.7% |
| Q4 2025 | $312.7M | +3.6% |
| Q3 2025 | $311.5M | +0.6% |
| Q2 2025 | $304.9M | +2% |
| Q1 2025 | $306.8M | +5.2% |
| Q4 2024 | $301.8M | +1.9% |
ACT's revenue has grown year over year for 16 quarters in a row: $313M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 65% | -2.5 points |
| Q2 2026 | 69% | -1 points |
| Q1 2026 | 68% | -0.5 points |
| Q4 2025 | 71% | +2.5 points |
| Q3 2025 | 67% | -6.8 points |
| Q2 2025 | 70% | -8.2 points |
| Q1 2025 | 69% | -1.7 points |
| Q4 2024 | 69% | +1.4 points |
ACT has the edge over BAC on profitability, with a higher operating margin.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over ACT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ACT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $183.9M | -4.2% |
| Q2 2026 | $118.5M | -0.8% |
| Q1 2026 | $224M | -1.2% |
| Q4 2025 | $186.3M | +12% |
| Q3 2025 | $192M | +2.1% |
| Q2 2025 | $119.5M | -17% |
| Q1 2025 | $226.7M | +21% |
| Q4 2024 | $166.1M | -13% |
ACT's free cash flow was $713M over the past year, up 1.2% from the year before. Free cash flow isn't a meaningful measure for financial services companies like ACT.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over ACT on cash flow, with more consistent year-over-year improvement.
ACT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -2M shares |
| 1 year | -6.8% | -10M shares |
| 3 years | -14% | -22.9M shares |
| 5 years | -15% | -24.6M shares |
| Available history | -15% | -24.5M shares |
ACT has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $117.9M |
| Q2 2026 | $93.3M |
| Q1 2026 | $93.2M |
| Q4 2025 | $127M |
| Q3 2025 | $105.5M |
| Q2 2025 | $84.6M |
| Q1 2025 | $65.3M |
| Q4 2024 | $74.6M |
ACT spent $431M buying back its own shares over the past year, up 31% from the year before.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ACT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 0.5x | Very low |
| Q4 2020 | 0.6x | Very low |
| Q3 2020 | 0.3x | Very low |
| Q2 2020 | -0.6x | Net Cash |
| Q4 2019 | -0.4x | Net Cash |
ACT's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago. Net leverage isn't a meaningful measure for financial services companies like ACT.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ACT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.5 | Neutral |
| Stochastic | 47.2 | Neutral |
ACT's weekly RSI is 49 (neutral) and its Stochastic is 47 (neutral).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ACT PE vs Financial Services Sector
| Metric | ACT | Sector median | Relative |
|---|---|---|---|
| PE | 9.5x | 13x | 27% below |
| PE % | 90 | 65 | 25 pts above |
ACT has the edge over BAC on valuation relative to its sector.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ACT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.5 | 1.4% below |
| 20 week MA | $47.3 | 3.2% below |
| 50 week MA | $43.8 | 4.6% above |
| 100 week MA | $39.7 | 15% above |
| 200 week MA | $34.3 | 33% above |
ACT has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ACT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $20.0 | $20.0 | +0.1% |
| 2022 | $20.0 | $24.2 | +21% |
| 2023 | $24.2 | $28.9 | +19% |
| 2024 | $28.9 | $32.4 | +12% |
| 2025 | $32.4 | $40.1 | +24% |
| 2026 YTD | $40.1 | $45.8 | +14% |
ACT has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.